China Resources Pharmaceutical Group Ltd
HKEX:3320
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
HK |
|
A
|
Allegiant Professional Business Services Inc
OTC:APRO
|
US |
|
Embla Medical hf
CSE:EMBLA
|
IS |
|
H
|
HK Acquisition Corp
HKEX:7841
|
HK |
|
A
|
Allane SE
XETRA:LNSX
|
DE |
|
Y
|
Yushiro Chemical Industry Co Ltd
TSE:5013
|
JP |
|
Asti Corp
TSE:6899
|
JP |
|
Inficon Holding AG
SIX:IFCN
|
CH |
|
Gujarat Craft Industries Ltd
BSE:526965
|
IN |
|
M
|
Maple Gold Mines Ltd
OTC:MGMLF
|
CA |
Wall Street
Price Targets
Price Targets Summary
China Resources Pharmaceutical Group Ltd
According to Wall Street analysts, the average 1-year price target for China Resources Pharmaceutical Group Ltd is 6.65 HKD with a low forecast of 5.42 HKD and a high forecast of 9.24 HKD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is China Resources Pharmaceutical Group Ltd's stock price target?
Price Target
6.65
HKD
According to Wall Street analysts, the average 1-year price target for China Resources Pharmaceutical Group Ltd is 6.65 HKD with a low forecast of 5.42 HKD and a high forecast of 9.24 HKD.
What is China Resources Pharmaceutical Group Ltd's Revenue forecast?
Projected CAGR
7%
For the last 11 years the compound annual growth rate for China Resources Pharmaceutical Group Ltd's revenue is 6%. The projected CAGR for the next 2 years is 7%.
What is China Resources Pharmaceutical Group Ltd's Operating Income forecast?
Projected CAGR
9%
For the last 11 years the compound annual growth rate for China Resources Pharmaceutical Group Ltd's operating income is 5%. The projected CAGR for the next 2 years is 9%.
What is China Resources Pharmaceutical Group Ltd's Net Income forecast?
Projected CAGR
4%
For the last 11 years the compound annual growth rate for China Resources Pharmaceutical Group Ltd's net income is 4%. The projected CAGR for the next 2 years is 4%.
